Genmab Has First Wholly Owned Antibodies In Phase III, Hunts For More

Shifting From Out-Licensing To Retaining Assets

 
• By Mandy Jackson
  
Genmab bought ProfoundBio last year and hopes to sign another deal this year (Shutterstock)

More from Deals

More from Scrip